MedPath

Endevica Bio

Endevica Bio logo
🇺🇸United States
Ownership
Holding
Established
2009-01-01
Employees
1
Market Cap
-
Website
http://endevicabio.com

Optimizing Body Mass Index (BMI) With TCMCB07, The Paradox Trial

Phase 2
Recruiting
Conditions
Cachexia; Cancer
Interventions
Drug: Placebo
First Posted Date
2025-04-22
Last Posted Date
2025-05-14
Lead Sponsor
Endevica Bio
Target Recruit Count
100
Registration Number
NCT06937177
Locations
🇨🇦

Investigative Site, Edmonton, Alberta, Canada

A Study to Assess the Safety, Tolerability and Pharmacokinetics of TCMCB07 in Single and Multiple Ascending Doses in Health Subjects

Phase 1
Completed
Conditions
Cachexia
Interventions
Drug: Placebo
First Posted Date
2022-09-07
Last Posted Date
2024-02-21
Lead Sponsor
Endevica Bio
Target Recruit Count
76
Registration Number
NCT05529849
Locations
🇺🇸

Quotient Sciences -- Miami, Inc., Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath